BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9675126)

  • 21. Active-site titration of serine proteases in organic solvents.
    Wangikar PP; Carmichael D; Clark DS; Dordick JS
    Biotechnol Bioeng; 1996 May; 50(3):329-35. PubMed ID: 18626960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locating interaction sites on proteins: the crystal structure of thermolysin soaked in 2% to 100% isopropanol.
    English AC; Done SH; Caves LS; Groom CR; Hubbard RE
    Proteins; 1999 Dec; 37(4):628-40. PubMed ID: 10651278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular dichroism and fluorescence of polyethylene glycol-subtilisin in organic solvents.
    Pasta P; Riva S; Carrea G
    FEBS Lett; 1988 Aug; 236(2):329-32. PubMed ID: 3044827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-directed and random immobilization of subtilisin on functionalized membranes: activity determination in aqueous and organic media.
    Viswanath S; Wang J; Bachas LG; Butterfield DA; Bhattacharyya D
    Biotechnol Bioeng; 1998 Dec; 60(5):608-16. PubMed ID: 10099469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multinuclear NMR study of enzyme hydration in an organic solvent.
    Lee CS; Ru MT; Haake M; Dordick JS; Reimer JA; Clark DS
    Biotechnol Bioeng; 1998 Mar; 57(6):686-93. PubMed ID: 10099248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate desolvation as a governing factor in enzymatic transformations of PAHs in aqueous-acetonitrile mixtures.
    Borole AP; Cheng CL; Davison BH
    Biotechnol Prog; 2004; 20(4):1251-4. PubMed ID: 15296456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organic solvents identify specific ligand binding sites on protein surfaces.
    Liepinsh E; Otting G
    Nat Biotechnol; 1997 Mar; 15(3):264-8. PubMed ID: 9062927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of catalytic efficiency of enzymes through exposure to anhydrous organic solvent at 70 degrees C. Three-dimensional structure of a treated serine proteinase at 2.2 A resolution.
    Gupta MN; Tyagi R; Sharma S; Karthikeyan S; Singh TP
    Proteins; 2000 May; 39(3):226-34. PubMed ID: 10737944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate-binding proteins: Dissecting ligand structures through solvent environment occupancy.
    Gauto DF; Di Lella S; Guardia CM; Estrin DA; Martí MA
    J Phys Chem B; 2009 Jun; 113(25):8717-24. PubMed ID: 19485380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The X-ray structure of zebrafish (Danio rerio) ileal bile acid-binding protein reveals the presence of binding sites on the surface of the protein molecule.
    Capaldi S; Saccomani G; Fessas D; Signorelli M; Perduca M; Monaco HL
    J Mol Biol; 2009 Jan; 385(1):99-116. PubMed ID: 18952094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic activity and conformation of chemically modified subtilisin Carlsberg in organic media.
    Kwon OH; Imanishi Y; Ito Y
    Biotechnol Bioeng; 1999; 66(4):265-70. PubMed ID: 10578097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the mechanism of biological methane formation: structural evidence for conformational changes in methyl-coenzyme M reductase upon substrate binding.
    Grabarse W; Mahlert F; Duin EC; Goubeaud M; Shima S; Thauer RK; Lamzin V; Ermler U
    J Mol Biol; 2001 May; 309(1):315-30. PubMed ID: 11491299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of crown ethers on structure, stability, activity, and enantioselectivity of subtilisin Carlsberg in organic solvents.
    Santos AM; Vidal M; Pacheco Y; Frontera J; Báez C; Ornellas O; Barletta G; Griebenow K
    Biotechnol Bioeng; 2001 Aug; 74(4):295-308. PubMed ID: 11410854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state.
    Mayer ML; Olson R; Gouaux E
    J Mol Biol; 2001 Aug; 311(4):815-36. PubMed ID: 11518533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineered Bacillus lentus subtilisins having altered flexibility.
    Graycar T; Knapp M; Ganshaw G; Dauberman J; Bott R
    J Mol Biol; 1999 Sep; 292(1):97-109. PubMed ID: 10493860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding site detection and druggability index from first principles.
    Seco J; Luque FJ; Barril X
    J Med Chem; 2009 Apr; 52(8):2363-71. PubMed ID: 19296650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental and computational mapping of the binding surface of a crystalline protein.
    English AC; Groom CR; Hubbard RE
    Protein Eng; 2001 Jan; 14(1):47-59. PubMed ID: 11287678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting proteinase specificities from free energy calculations.
    Mekonnen SM; Olufsen M; Smalås AO; Brandsdal BO
    J Mol Graph Model; 2006 Oct; 25(2):176-85. PubMed ID: 16386933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogen/deuterium exchange study of subtilisin Carlsberg during prolonged exposure to organic solvents.
    Fasoli E; Ferrer A; Barletta GL
    Biotechnol Bioeng; 2009 Mar; 102(4):1025-32. PubMed ID: 18985614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.